$12M Vioxx Deal Requires Merck To Add Safety Checks
A New Jersey state judge has preliminarily approved a settlement of a Vioxx-related shareholder derivative action that will see Merck & Co. Inc. institute stronger drug-safety measures, appoint a chief medical...To view the full article, register now.
Already a subscriber? Click here to view full article